STF-31 in cancer cell lines also targets Glut1, and it has been proposed that STF-31 also exerts an additional inhibitory effect because dual functions are beneficial for inducing cell death in tumors with a high glucose consumption rate. This evidence concerns the gene SLC2A1 and cancer.